Video 3: MDT perspectives on identifying and managing key ADC treatment toxicities in patients with metastatic breast cancer

Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer.

The multidisciplinary team

• Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
• Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
• Clinical oncology pharmacy specialist: Dr Scott Edwards, Dr. H. Bliss Murphy Cancer Center, St. John’s, Newfoundland, Canada

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Gilead Sciences, Inc.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchONCOLOGY.com